{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:42:19Z","timestamp":1761050539948,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1006\/bcmd.1999.0248","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T14:39:06Z","timestamp":1034001546000},"page":"227-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of New Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS) and Eosinophilia"],"prefix":"10.1006","volume":"25","author":[{"given":"A.I","family":"Aspinall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.A","family":"Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Luider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Dimnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.D","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Jorgenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/bcmd.1999.0248_RF1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-3476(98)70102-7","article-title":"The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis","volume":"133","author":"Infante","year":"1998","journal-title":"J Pediatr"},{"key":"10.1006\/bcmd.1999.0248_RF2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1006\/bcmd.1999.0248_RF3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)65742-2","article-title":"Pathological findings in human autoimmune lymphoproliferative syndrome","volume":"153","author":"Lim","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1006\/bcmd.1999.0248_RF4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJM199611283352204","article-title":"Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity","volume":"335","author":"Drappa","year":"1996","journal-title":"N. Engl J Med"},{"key":"10.1006\/bcmd.1999.0248_RF5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1006\/bcmd.1999.0248_RF6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V89.3.902","article-title":"Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis","volume":"89","author":"Bettinardi","year":"1997","journal-title":"Blood"},{"key":"10.1006\/bcmd.1999.0248_RF7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1084\/jem.183.3.1071","article-title":"Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia","volume":"183","author":"Simon","year":"1996","journal-title":"J Exp Med"},{"key":"10.1006\/bcmd.1999.0248_RF8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bmt.1701306","article-title":"Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation","volume":"22","author":"Sleight","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1006\/bcmd.1999.0248_RF9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/intimm\/10.2.195","article-title":"Novel Fas (CD95\/APO-1) mutations in infants with a lymphoproliferative disorder","volume":"10","author":"Kasahara","year":"1998","journal-title":"Int Immunol"},{"key":"10.1006\/bcmd.1999.0248_RF10","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V89.8.2871","article-title":"Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity\/lymphoproliferation","volume":"89","author":"Dianzani","year":"1997","journal-title":"Blood"},{"key":"10.1006\/bcmd.1999.0248_RF11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.183.3.721","article-title":"Fas and the Art of Lymphocyte Maintenance","volume":"183","author":"Lenardo","year":"1996","journal-title":"J Exp Med"},{"key":"10.1006\/bcmd.1999.0248_RF12","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.4049\/jimmunol.152.10.4861","article-title":"Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis on interaction with a third CD2 monoclonal antibody","volume":"152","author":"Rouleau","year":"1994","journal-title":"J Immunol"},{"key":"10.1006\/bcmd.1999.0248_RF13","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1182\/blood.V92.10.3904","article-title":"Eosinophil tethering to interleukin-4-activated endothelial cells requires both P-selectin and vascular cell adhesion molecule-1","volume":"92","author":"Patel","year":"1998","journal-title":"Blood"},{"key":"10.1006\/bcmd.1999.0248_RF14","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2057::AID-IMMU2057>3.0.CO;2-T","article-title":"Differential regulation of CD95 (Fas\/APO-1) expression in human blood eosinophils","volume":"28","author":"Luttmann","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1006\/bcmd.1999.0248_RF15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0145-2126(98)00013-7","article-title":"Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis","volume":"22","author":"Pepper","year":"1998","journal-title":"Leuk Res"},{"key":"10.1006\/bcmd.1999.0248_RF16","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.4049\/jimmunol.157.9.3980","article-title":"A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells","volume":"157","author":"Zhang","year":"1996","journal-title":"J Immunol"},{"key":"10.1006\/bcmd.1999.0248_RF17","first-page":"45","article-title":"Prediction of the secondary structure of proteins from their amino acid sequence","volume":"47","author":"Chou","year":"1978","journal-title":"Adv Enzymol"},{"key":"10.1006\/bcmd.1999.0248_RF18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-2836(78)90297-8","article-title":"Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins","volume":"120","author":"Garnier","year":"1978","journal-title":"J Mol Biol"},{"key":"10.1006\/bcmd.1999.0248_RF19","doi-asserted-by":"crossref","first-page":"10932","DOI":"10.1016\/S0021-9258(18)82075-0","article-title":"A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen","volume":"268","author":"Itoh","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1006\/bcmd.1999.0248_RF20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","article-title":"Murine models of systemic lupus erythematosus","volume":"37","author":"Theofilopoulos","year":"1968","journal-title":"Adv Immunol"},{"key":"10.1006\/bcmd.1999.0248_RF21","first-page":"73","article-title":"Molecular genetic studies in lymphocyte apoptosis and human autoimmunity","volume":"215","author":"Martin","year":"1998","journal-title":"Novartis Found Symp"},{"key":"10.1006\/bcmd.1999.0248_RF22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0092-8674(95)90071-3","article-title":"FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis","volume":"81","author":"Chinnaiyan","year":"1995","journal-title":"Cell"},{"key":"10.1006\/bcmd.1999.0248_RF23","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.158.4.1912","article-title":"Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity","volume":"158","author":"Fuss","year":"1997","journal-title":"J Immunol"},{"key":"10.1006\/bcmd.1999.0248_RF24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/intimm\/6.10.1545","article-title":"Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death","volume":"6","author":"Ramsdell","year":"1994","journal-title":"Int Immunol"},{"key":"10.1006\/bcmd.1999.0248_RF25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.185.10.1837","article-title":"Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas\/FasL-mediated apoptosis","volume":"185","author":"Zhang","year":"1997","journal-title":"J Exp Med"},{"key":"10.1006\/bcmd.1999.0248_RF26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(00)80587-7","article-title":"Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia","volume":"9","author":"Traver","year":"1998","journal-title":"Immunity"},{"key":"10.1006\/bcmd.1999.0248_RF27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1006\/bcmd.1999.0248_RF28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.275.5302.960","article-title":"Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis","volume":"275","author":"Giordano","year":"1997","journal-title":"Science"},{"key":"10.1006\/bcmd.1999.0248_RF29","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1182\/blood.V90.11.4266","article-title":"Mutations in the Fas antigen in patients with multiple myeloma","volume":"90","author":"Landowski","year":"1997","journal-title":"Blood"},{"key":"10.1006\/bcmd.1999.0248_RF30","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V91.10.3943","article-title":"CD95 (APO-1\/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia","volume":"91","author":"Beltinger","year":"1998","journal-title":"Blood"},{"key":"10.1006\/bcmd.1999.0248_RF31","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","article-title":"Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity","volume":"92","author":"Gronbaek","year":"1998","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979699902486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979699902486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:18:01Z","timestamp":1761049081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979699902486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["S1079979699902486"],"URL":"https:\/\/doi.org\/10.1006\/bcmd.1999.0248","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[1999,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of New Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS) and Eosinophilia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/bcmd.1999.0248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}